Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Thrive Health Solutions Injectables Recalled for Lack of Sterility Assurance

Agency Publication Date: June 23, 2025
Share:
Sign in to monitor this recall

Summary

Thrive Health Solutions (Colorado) is recalling 1,799 pre-filled syringes of various injectable medications, including Semaglutide, Tirzepatide, and NAD+. The recall was initiated because the products lack assurance of sterility, meaning they may not be free from harmful microorganisms. Using a non-sterile injectable product can lead to serious infections at the injection site or throughout the body.

Risk

The lack of sterility assurance poses a risk of infection to patients who receive these injections. While no injuries have been reported to date, contaminated injectable drugs can introduce bacteria or fungi directly into the body, potentially causing life-threatening complications.

What You Should Do

  1. This recall affects multiple injectable medications sold under the Thrive Health Solutions brand, including Methylcobalamin, CJC-1295, LL Bioboost, LX Bioboost Plus, NAD+, Semaglutide, and Tirzepatide pre-filled syringes.
  2. Check the lot number and expiration date printed on the pre-filled syringe label to see if your medication is included. See the Affected Products section below for the full list of affected codes.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund.
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Methylcobalamin Injectable (10mg/mL)
Variants: 10mg/mL, Pre-filled syringe
Lot Numbers:
H228307 (Exp 12/27/2025)

Quantity: 5 syringes

Product: CJC-1295 Injectable (6mg/15mg)
Variants: 6mg/15mg, Pre-filled syringe
Lot Numbers:
H261968 (Exp 12/23/2025)
H261358 (Exp 5/13/2025)

Quantity: 60 syringes

Product: LL Bioboost Injectable (Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, Cyanocobalamin 1 mg)
Variants: Pre-filled syringe
Lot Numbers:
H277639 (Exp 6/25/2025)

Quantity: 64 syringes

Product: LX Bioboost Plus Injectable
Variants: Pre-filled syringe
Lot Numbers:
H227226 (Exp 12/24/2025)
H360175 (Exp 6/2/2025)
H368308 (Exp 6/2/2025)
S360175 (Exp 6/2/2025)

Each 1mL contains Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, Pyridoxine HCl 25 mg, Dexpanthenol 25 mg, Cyanocobalamin 1 mg, L-Arginine HCl 15 mg, L-Carnitine 15 mg, and Lidocaine 1 mg; Quantity: 102 syringes

Product: Nicotinamide adenine dinucleotide (NAD+)
Variants: 100mg/mL, Pre-filled syringe
Lot Numbers:
O-O8A01-25 (Exp 3/7/2025)
GA37484

Quantity: 32 syringes total across two recall IDs

Product: Semaglutide Injectable (2.5 mg/mL)
Variants: 2.5 mg/mL, Pre-filled syringe
Lot Numbers:
H270221 (Exp 12/26/2025)

Quantity: 32 syringes

Product: Semaglutide Injectable (5 mg/mL)
Variants: 5 mg/mL, Pre-filled syringe
Lot Numbers:
C03035J (Exp 7/3/2025)
H202959 (Exp 7/6/2025)
AB20N110720 (Exp 7/7/2025)
AB60N1121 (Exp 7/7/2025)
PRX022225-1 (Exp 8/24/2025)
U122024 (Exp 10/26/2025)

Quantity: 164 syringes

Product: Semaglutide/Cyanocobalamin Injectable (5mg/1mg/mL)
Variants: 5mg/1mg/mL, Pre-filled syringe
Lot Numbers:
C03075J (Exp 7/7/2025)

Quantity: 28 syringes

Product: Tirzepatide Injections (10mg/mL)
Variants: 10mg/mL, Pre-filled syringe
Lot Numbers:
H272962 (Exp 12/5/2025)
S5045185 (Exp 5/20/2025)
H270625 (Exp 9/30/2025)

Quantity: 24 syringes

Product: Tirzepatide Injections (20mg/mL)
Variants: 20mg/mL, Pre-filled syringe
Lot Numbers:
BH11235 (Exp 5/5/2025)
PRX11212024 (Exp 5/20/2025)
BH272962 (Exp 5/20/2025)
BH00048 (Exp 5/20/2025)
PRX12825-2 (Exp 7/27/2025)
PRO30625-2 (Exp 9/2/2025)
PRX012825-2 (Exp 9/27/2025)
AB11212024 (Exp 11/21/2025)
BH66-1002 (Exp 12/30/2025)

Quantity: 826 syringes

Product: Tirzepatide Injections (30mg/mL)
Variants: 30mg/mL, Pre-filled syringe
Lot Numbers:
H388348

Quantity: 4 syringes

Product: Tirzepatide/Cyanocobalamin Injectable (15mg/1mg/mL)
Variants: 15mg/1mg/mL, Pre-filled syringe
Lot Numbers:
C03065F

Quantity: 216 syringes

Product: Tirzepatide/Cyanocobalamin Injectable (30mg/1mg/mL)
Variants: 30mg/1mg/mL (15mg/0.5mg/0.5mL), Pre-filled syringe
Lot Numbers:
C03125A

Quantity: 242 syringes

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 96742
Status: Active
Manufacturer: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
Sold By: Thrive Health Solutions
Manufactured In: United States
Units Affected: 14 products (5; 60 syringes; 64 syringes; 102 syringes; 16 syringes; 32 syringes; 164 syringes; 28 syringes; 24 syringes; 826 syringes; 4 syringes; 216 syringes; 242 syringes; 16 syringes)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.